tm
Seeing Is Believing
tm
Seeing Is Believing
GALT is currently covered by 1 analysts with an average price target of $6.18. This is a potential upside of $4.84 (361.19%) from yesterday's end of day stock price of $1.34.
Galectin Therapeutics's activity chart (see below) currently has 7 price targets and 12 ratings on display. The stock rating distribution of GALT is 66.67% BUY and 33.33% HOLD.
Analysts average stock forecasts to be materialized ratio is 70.83% with an average time for these price targets to be met of 135.67 days.
Highest price target for GALT is $3, Lowest price target is $1.
Most recent stock forecast was given by ED ARCE from HC WAINWRIGHT on 02-Apr-2025. First documented stock forecast 28-Mar-2016.
Currently out of the existing stock ratings of GALT, 4 are a BUY (66.67%), 2 are a HOLD (33.33%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
21 days ago
(02-Apr-2025)
1/8 (12.5%)
$8.23 (297.11%)
168
Buy
$8
$6.29 (367.84%)
$3
7 years 3 months 19 days ago
(04-Jan-2018)
3/3 (100%)
$3.74 (87.79%)
140
Buy
$5
$3.29 (192.40%)
$2
7 years 6 months 17 days ago
(06-Oct-2017)
3/3 (100%)
$2.56 (104.92%)
99
What is GALT (Galectin Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on GALT (Galectin Therapeutics) with a proven track record?
Which analyst has the current lower performing score on GALT (Galectin Therapeutics) with a proven track record?
Which analyst has the most public recommendations on GALT (Galectin Therapeutics)?
Which analyst is the currently most bullish on GALT (Galectin Therapeutics)?
Which analyst is the currently most reserved on GALT (Galectin Therapeutics)?
